Elutia (ELUT) Net Equity Issued and Repurchased (2020 - 2025)
Elutia's (ELUT) quarterly Net Equity Issued and Repurchased came in at $13.8 million in Q1 2025, up 359.87% quarter-over-quarter from $3.0 million in Q3 2020.
Powered by 
Analysis
Elutia (ELUT) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Elutia has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $13.8 million for Q1 2025.
- In Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $13.8 million; the TTM figure through Sep 2025 stood at $13.8 million (up 359.87% YoY), while the FY2020 annual figure was $3.4 million, up 50.66% from the prior year.
- Net Equity Issued and Repurchased came in at $13.8 million for Q1 2025 at Elutia, up from $3.0 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $13.8 million in Q1 2025 to a low of $13.8 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Elutia | 35.28 Mn | 15.39 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 13.80 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Mar 31, 2020 | 450,000.00 |